Skip to content

Purps

Tilray
THC22%
CBD≤1%
GeneticsHybrid/Indica
CountryPortugalia Portugal
Packaging15g
Tilray THC 22%18,65 zł/g – 33,33 zł/g

Pharmacy data may be outdated — last successful update: 9 days ago.

Lineage: nieznany rodówód

A hybrid strain from Tilray with a majority of indica genes (approx. 70%), distinguished by deep, calming effects and an intense aroma. Ideal for late afternoon and evening. Thanks to high limonene and linalool content, it offers relaxation and mood improvement. Patients report an analgesic effect at lower doses, and deeper relaxation with improved sleep quality at higher doses.

What this description is based on: the strain's terpene profile and cannabinoid content, not clinical trials of this product. The terpene profile is approximate. The type of study behind each terpene effect is given in the Terpene Encyclopedia, and clinical publications are collected in Cannabis Research. Where the data comes from

SourFruityEarthy

Patient Experiences

✅
100% positive0% neutral0% negative

Based on 6 patient reviews

AI summary of publicly available opinions

Patient reports indicate that the herb effectively alleviates back pain and symptoms of ankylosing spondylitis. Some individuals note assistance in reducing anxiety and improving mood. Patients report varying effects on energy levels: some describe initial stimulation, while others experience evening relaxation and improved sleep onset. Feedback suggests that the product vaporizes well, although its visual appearance is not always optimal.

"Po waporyzacji efekty świetnie zadziałały na mój ból pleców, przynosząc ulgę bez wywoływania nadmiernego sennego uczucia. Produkt palił się naprawdę dobrze."

— opinion from a public source (Reddit)

This summary was written automatically by an AI model from 6 opinions in public sources (Budcare.pl, Reddit). Updated: 22/11/2026. These are individual patient experiences, not clinical trial results — they cannot predict the effect in a particular person. Discuss your choice of strain with a doctor. How summaries are made

Reviews submitted by patients on TerpeneAtlas (0)

Reviews written directly on the website and published after the administrator approves them. They are not part of the AI summary above.

No one has reviewed this strain directly on the website yet. If you use it, describe your experience: your review will appear here once approved and will help other patients.

Be first when Tilray releases a new strain

Terpene Profile

  • Caryophyllene: 25%
  • Nerolidol: 24%
  • Bisabolol: 11%
  • Limonene: 11%
  • Humulene: 9%
  • Linalool: 8%
  • Myrcene: 6%
  • Pinene: 5%
  • Ocimene: 1%
  • CaryophylleneCaryophyllene
  • NerolidolNerolidol
  • BisabololBisabolol
  • LimoneneLimonene
  • HumuleneHumulene
  • LinaloolLinalool
  • MyrceneMyrcene
  • PinenePinene
  • OcimeneOcimene

Terpene release temperatures

Each terpene releases at its boiling point — set your vaporizer to target a specific profile.

Aromatic phase 160–180°CGolden standard 180–205°CFull extraction 205–220°CPyrolysis
PinenPinen5%
155°C
MircenMircen6%
168°C
LimonenLimonen11%
176°C
OcymenOcymen1%
177°C
LinalolLinalol8%
198°C
KariofilenKariofilen25%
263°C
HumulenHumulen9%
276°C
NerolidolNerolidol24%
277°C
BisabololBisabolol11%
314°C
150°C180°C205°C220°C230°C

Vaporization Temperature Calculator

Optimal range based on the strain's terpene profile and scientific research

Recommended range:195°C – 215°CApproximate range (editorial judgement): monoterpenes degrade from around 200 °C, so a profile dominated by them is better set lower.

The temperature range is an editorial heuristic based on the terpene profile, not a clinical recommendation. Dosage and method of use are determined solely by your treating physician.

Vaporization phases

Four compound-release phases on a single temperature scale

Aromatic phase

160–180°C

Mainly terpenes, low toxicity

Golden standard

180–205°C

THC + CBD + light terpenes

Full extraction

205–220°C

Heavy terpenes (caryophyllene, humulene, nerolidol)

Pyrolysis

220–230°C

Rising risk of breakdown and combustion products — device-dependent

195°C
150°160°180°205°220°230°
150°C195°C · Golden standard230°C
Range most often used in vaporization research: 180–210°C

(approximate scale)

Released abundantly (5)

PinenPinen· 5% · Degr. from 300°CMircenMircen· 6% · Degr. from 200°CLimonenLimonen· 11% · Degr. from 200°COcymenOcymen· 1% · Degr. from 200°CLinalolLinalol· 8% · Degr. from 350°C

Partially released (4)

KariofilenKariofilen· 25% · Boils at 263°CHumulenHumulen· 9% · Boils at 276°CNerolidolNerolidol· 24% · Boils at 277°CBisabololBisabolol· 11% · Boils at 314°C

Terpenes release gradually as temperature rises — the evaporation rate depends on the saturated vapor pressure, which increases exponentially with temperature and reaches atmospheric pressure at the boiling point. Below this threshold terpenes evaporate more slowly but still in noticeable amounts, and do not undergo thermal degradation. Each terpene has its own thermal degradation threshold (shown as „degr. from”) — the process is driven by heat energy. In addition to thermal degradation, terpenes also undergo oxidative degradation through contact with oxygen, light and moisture at temperatures below the thermal degradation threshold — which is why it is important to keep the herb out of the sun, in as dark an environment as possible, and to use humidity controllers.

Scientific sources
  • Pomahacova et al. 2009 (PMID 19852551) — cannabinoid-to-byproduct ratio was significantly better at 200 and 230 °C than in smoke, and worst at 170 °C
  • Hazekamp et al. 2006 (PMID 16637053) — evaluation of the Volcano vaporizer with pure THC: vaporization efficiency and reproducibility
  • Lanz et al., Medical Cannabis and Cannabinoids, 2016
  • McGraw et al., USDA Forest Service — thermal degradation of terpenes, 1999
  • Russo, British Journal of Pharmacology, 2011
  • Gieringer et al., MAPS/NORML, 2004

Price history · last 30 days

GdziePoLek price range, not a specific pharmacy offer. Only real observations are saved; a missing observation does not mean unavailable stock.

26.1029.1001.1104.1107.1110.1113.1116.1119.1122.111520253035
  • Minimum
  • Maximum
Chart data (zł/g)
DateMin.Max.
2026-10-2418.3633.90
2026-10-2519.0833.90
2026-10-2619.0833.90
2026-10-2719.0833.90
2026-10-2819.3033.90
2026-10-2919.3033.90
2026-10-3019.2733.90
2026-10-3119.2733.90
2026-11-0118.4033.90
2026-11-0218.4033.90
2026-11-0318.4033.33
2026-11-0418.4033.33
2026-11-0518.4033.33
2026-11-0618.4033.33
2026-11-0718.4033.33
2026-11-0818.4033.33
2026-11-0918.4033.33
2026-11-1018.6533.33
2026-11-1118.6533.33
2026-11-1218.6533.33
2026-11-13——
2026-11-14——
2026-11-15——
2026-11-16——
2026-11-17——
2026-11-18——
2026-11-19——
2026-11-20——
2026-11-21——
2026-11-22——

First observation in this period: 2026-10-24. Gaps mean no observation; — means no price.

Book a consultation

Discuss your strain choice with a cannabis medicine doctor

Strains with Similar Terpene Profiles

Purps

in pharmacies

S-Lab

100% profile match

Hybrid/IndicaTHC 18%CBD ≤1%

Main terpenes

KariofilenCaryophylleneNerolidolNerolidolLimonenLimonene
Packaging:15g

Purps

in pharmacies

Synoptis Pharma

100% profile match

Hybrid/IndicaTHC 22%CBD ≤1%

Main terpenes

KariofilenCaryophylleneNerolidolNerolidolLimonenLimonene
Packaging:15g

Rockstar

in pharmacies

S-Lab

94% profile match

IndicaTHC 18%CBD ≤1%

Main terpenes

NerolidolNerolidolKariofilenCaryophylleneBisabololBisabolol
Packaging:15g

Rockstar

in pharmacies

S-Lab

94% profile match

IndicaTHC 22%CBD ≤1%

Main terpenes

NerolidolNerolidolKariofilenCaryophylleneBisabololBisabolol
Packaging:15g

Galaxy Walker OG

in pharmacies

S-Lab

92% profile match

Hybrid/IndicaTHC 18%CBD ≤1%

Main terpenes

NerolidolNerolidolKariofilenCaryophylleneBisabololBisabolol
Packaging:15g

Galaxy Walker OG

in pharmacies

S-Lab

92% profile match

Hybrid/IndicaTHC 22%CBD ≤1%

Main terpenes

NerolidolNerolidolKariofilenCaryophylleneBisabololBisabolol
Packaging:15g

TerpeneAtlas is run by Ewa Jastrzębska, physician · Indywidualna Praktyka Lekarska Ewa Jastrzębska

TerpeneAtlas.Strain card · for clinicians and patients

Tilray

Purps

Tilray THC 22%

THC22%
CBD≤1%
GeneticsHybrid/Indica

A hybrid strain from Tilray with a majority of indica genes (approx. 70%), distinguished by deep, calming effects and an intense aroma. Ideal for late afternoon and evening. Thanks to high limonene and linalool content, it offers relaxation and mood improvement. Patients report an analgesic effect at lower doses, and deeper relaxation with improved sleep quality at higher doses.

SourFruityEarthy
Caryophyllene
Dominant terpeneCaryophyllene

Product information

Producer
Tilray
THC / CBD
22% / ≤1%
Packaging
15g
Product code (EAN/GTIN)
No verified code in the catalogue
GdziePoLek ID (not EAN)
129656
Availability
Unconfirmed
Availability updated
12/11/2026, 21:44:58

Catalogue terpene profile

kariofilen: 25%, nerolidol: 24%, bisabolol: 11%, limonen: 11%, humulen: 9%, linalol: 8%, mircen: 6%, pinen: 5%, ocymen: 1%TerpenesTerpeneAtlas
TerpeneProfile (%)
Caryophyllene25
Nerolidol24
Bisabolol11
Limonene11
Humulene9
Linalool8
Myrcene6
Pinene5
Ocimene1

Profile values are not terpene concentrations in the flower or a batch-specific certificate of analysis (COA). Verify the product, strength, packaging and code in the current registry or product documentation before prescribing. Availability may change.